Heights Capital Management’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Heights Capital Management's IRD Position: Q1 2019 in Review
Heights Capital Management sold out of Opus Genetics (IRD) in Q1 2019, closing a stake of 32,247 shares — an estimated $1.44M sold.
Heights Capital Management first reported a position in IRD in Q4 2018 and held it in 1 quarter. The position peaked at $1.44M in Q4 2018. 28 funds tracked by Wall St. Rank hold IRD as of Q1 2019.
- Heights Capital Management reported no remaining Opus Genetics position as of Q1 2019 after selling out during the quarter.
- Heights Capital Management sold 32,247 Opus Genetics shares in Q1 2019, an estimated $1.44M.
- Heights Capital Management first reported a position in Opus Genetics in Q4 2018 and held it in 1 quarter.
- Heights Capital Management's Opus Genetics position peaked at $1.44M in Q4 2018.
- 28 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2019.
Based on Heights Capital Management's 13F filing for Q1 2019, filed 15 May 2019.